Fujifilm (OTCMKTS:FUJIY) Stock Price Crosses Above 200 Day Moving Average - What's Next?

Key Points

• Fujifilm Holdings Corp. recently saw its share price rise above its 200-day moving average, trading at $12.08 after hitting a high of $12.15.
• The company’s stock was downgraded from a "buy" to a "hold" rating by Wall Street Zen on May 23rd, indicating a potentially cautious outlook on the stock.
• Fujifilm reported a revenue of $5.08 billion for the last quarter, meeting analysts' expectations, with earnings per share of $0.15.

Shares of Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $10.50 and traded as high as $12.15. Fujifilm shares last traded at $12.08, with a volume of 129,379 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut shares of Fujifilm from a "buy" rating to a "hold" rating in a research report on Friday, May 23rd.

Fujifilm Price Performance

The company has a quick ratio of 0.92, a current ratio of 1.48 and a debt-to-equity ratio of 0.17. The firm's 50-day moving average is $10.98 and its 200-day moving average is $10.55. The company has a market cap of $29.31 billion, a PE ratio of 10.61, a PEG ratio of 2.26 and a beta of 0.67.

Fujifilm (OTCMKTS:FUJIY - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The technology company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. Fujifilm had a net margin of 7.93% and a return on equity of 7.60%. The company had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $760.41 billion. On average, equities analysts anticipate that Fujifilm Holdings Corp. will post 0.66 EPS for the current year.

Fujifilm Company Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.